Related Experiment Video
Updated: May 10, 2026

05:25
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
Effect of Phellius linteus water extract on benign prostatic hyperplasia
Yu-Na Kim1, Min-Sun Kim, Sung-Sik Chun
1Department of Food Science, International University of Korea, Gyeongnam 660-759, Korea.
Nutrition Research and Practice
|June 15, 2013
Summary
Phellinus linteus water extract may help treat benign prostatic hyperplasia (BPH). This study found it reduced prostate size and dihydrotestosterone (DHT) levels in rats, similar to the drug finasteride.
Area of Science:
- Urology
- Pharmacology
- Natural Product Research
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men, characterized by prostate enlargement.
- Dihydrotestosterone (DHT) plays a key role in promoting prostate growth in BPH.
- Current treatments often involve managing DHT levels, highlighting the need for effective therapeutic agents.
Purpose of the Study:
- To investigate the potential of Phellinus linteus water extract as a treatment for BPH.
- To evaluate the effects of Phellinus linteus on prostate size, weight, and hormone levels in a rat model of BPH.
Main Methods:
- Benign prostatic hyperplasia (BPH) was induced in Sprague-Dawley rats using testosterone treatments over 12 weeks.
- Rats were divided into four groups: control, testosterone + D.W. extract, testosterone + Phellinus linteus extract, and testosterone + finasteride.
- Prostate weight, volume, testosterone, and DHT levels were measured and compared across groups.
Main Results:
- Phellinus linteus extract significantly reduced prostate weight, volume, and weight ratio compared to the untreated BPH group.
- Testosterone and DHT levels were significantly decreased in the Phellinus linteus group compared to the untreated BPH group.
- Histological analysis showed reduced stromal proliferation and trophic changes in prostates treated with Phellinus linteus.
Conclusions:
- Phellinus linteus water extract demonstrates efficacy in reducing prostate enlargement and DHT levels in a BPH rat model.
- The findings suggest Phellinus linteus may serve as a potential natural remedy for managing benign prostatic hyperplasia.
- Further research is warranted to explore the mechanisms and clinical applications of Phellinus linteus for BPH treatment.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

